2012, Number 5
Next >>
Rev Mex Urol 2012; 72 (5)
El antígeno prostático específico, bajo la lupa. Cirugía radical para cáncer de próstata en controversia
Guzmán-Esquivel J
Language: Spanish
References: 5
Page: 217-219
PDF size: 57.80 Kb.
Text Extraction
No abstract
REFERENCES
Tangen CM, Hussain M, Higano CS, et al. Improved overall survival trends of men with newly diagnosed M1 prostate cancer: A SWOG phase III trial experience (S8494, S8894 and S9346). J Urol 2012;188(4):1164-1169.
Yossepowitch O, Eggener SE, Bianco FJ, et al. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol 2007;178:493-499.
Bianco FJ, Jr, Scardino PT, Eastham JA. Radical prostatectomy: longterm cancer control and recovery of sexual and urinary function (“trifecta”) Urology 2005;66(5 Suppl):83-94.
Klotz L. Active surveillance for prostate cancer: For Whom? J Clin Oncol 2005;23:8165-8169.
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203-213.
Full text